Symbiosis Pharma Services can integrate lyophilisation (freeze drying) or gas overlay to liquid fill options as part of aseptic filling processes within our GMP facility.
Lyophilisation is often favoured as a manufacturing step across biopharmaceuticals and small molecule drugs alike due to its contribution to product stability and handling. However, integrating a lyophilisation step should not be a last-minute decision, as development timelines can take several months.
Symbiosis has extensive experience in offering lyophilisation services as part of aseptic filling for small molecules and biopharmaceuticals such as mAbs.
Whether the lyophilisation cycle has been fully developed and is ready to be transferred or our expert team needs to assist with the development or optimisation of the cycle, we are experienced in handling a range of technical lyophilisation challenges directly, or in partnership with our trusted network.
We have two fully independent Tofflon lyophilisers contained within individual GMP manufacturing suites offering the following capabilities:
